Sun Pharma to Launch Generic Ozempic on ‘Day 1’ of Expiry

Sun Pharmaceutical Industries plans to start selling generic versions of semaglutide — the key ingredient in Novo Nordisk’s Ozempic and Wegovy — from “day 1” of the patent’s expiry in India, Managing Director Kirti Ganorkar said on an analyst call late Saturday.

• Sun will sell the medicine under the brands Noveltreat for chronic weight management and Sematrinity for diabetes, Ganorkar said
• The two products will be made available in “easy-to-use” injectable format and the co. has “sufficient supplies” to meet demand in India
• Sun to add field sales force for the two drugs, it said
• NOTE: Novo Nordisk’s India ...